ASCO® 2026 Highlights: Presenter Vignette – Susan Halabi
Susan Halabi
PhD, FASCO
Duke Cancer Institute
5018
Circulating tumor DNA–based clinical-genetic (CG) prognostic model for radiographic progression-free survival (rPFS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Analysis of Alliance A031201.